A. Pennathur, M. Gibson, B. Jobe, and J. Luketich, Oesophageal carcinoma, The Lancet, vol.381, issue.9864, pp.400-412, 2013.
DOI : 10.1016/S0140-6736(12)60643-6

Y. Zhang, Epidemiology of esophageal cancer, World Journal of Gastroenterology, vol.19, issue.34, pp.5598-606, 2013.
DOI : 10.3748/wjg.v19.i34.5598

P. Enzinger and R. Mayer, Esophageal Cancer. New Engl, J. Med, pp.2241-52, 2003.

L. Bedenne, P. Michel, O. Bouché, C. Milan, C. Mariette et al., Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102, Journal of Clinical Oncology, vol.25, issue.10, 2007.
DOI : 10.1200/JCO.2005.04.7118

URL : https://hal.archives-ouvertes.fr/hal-00363743

H. Van-westreenen, M. Westerterp, P. Bossuyt, J. Pruim, G. Sloof et al., F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer, Journal of Clinical Oncology, vol.22, issue.18, pp.3805-3817, 2004.
DOI : 10.1200/JCO.2004.01.083

V. Vliet, E. Heijenbrok-kal, M. Hunink, M. Kuipers, E. Siersema et al., Staging investigations for oesophageal cancer: a meta-analysis, British Journal of Cancer, vol.89, issue.3, pp.547-57, 2008.
DOI : 10.1136/gut.32.1.16

R. Downey, FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial, Journal of Clinical Oncology, vol.21, issue.3, pp.428-460, 2003.
DOI : 10.1200/JCO.2003.04.013

J. Omloo, M. Van-heijl, O. Hoekstra, M. Van-berge-henegouwen, J. Van-lanschot et al., FDG-PET parameters as prognostic factor in esophageal cancer patients: a review

C. Van-de-wiele, V. Kruse, P. Smeets, M. Sathekge, and A. Maes, Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours, European Journal of Nuclear Medicine and Molecular Imaging, vol.23, issue.5 Suppl, pp.290-301, 2013.
DOI : 10.1007/s00259-012-2280-z

D. Fiore, F. Blondin, V. Hitzel, A. Edet-sanson, A. Benyoucef et al., 18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinoma, Digestive and Liver Disease, vol.44, issue.10, pp.875-884, 2012.
DOI : 10.1016/j.dld.2012.04.017

URL : https://hal.archives-ouvertes.fr/hal-00942163

E. Touboul, F. Huguet, and J. Talbot, Apport de la TEP au diagnostic, ??valuation th??rapeutique et suivi du cancer de l?????sophage, Cancer/Radioth??rapie, vol.12, issue.6-7, pp.633-642, 2008.
DOI : 10.1016/j.canrad.2008.07.001

R. Kwee, Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Methods : Results : Conclusion : Radiology, pp.707-724, 2010.

O. Palie, P. Michel, J. Ménard, C. Rousseau, E. Rio et al., The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3) Eur

H. Wieder, B. Brücher, F. Zimmermann, K. Becker, F. Lordick et al., Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment, Journal of Clinical Oncology, vol.22, issue.5, pp.900-908, 2004.
DOI : 10.1200/JCO.2004.07.122

R. Blom, I. Steenbakkers, G. Lammering, R. Vliegen, E. Belgers et al., PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.53, issue.10, 2013.
DOI : 10.1007/s00259-013-2468-x

S. Hyun, J. Choi, Y. Shim, K. Kim, S. Lee et al., Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma, Annals of Surgical Oncology, vol.34, issue.1, pp.115-137, 2010.
DOI : 10.1245/s10434-009-0719-7

M. Mamede, P. Abreu-e-lima, M. Oliva, V. Nosé, H. Mamon et al., FDG-PET/CT Tumor Segmentation-Derived Indices of Metabolic Activity to Assess Response to Neoadjuvant Therapy and Progression-Free Survival in Esophageal Cancer, American Journal of Clinical Oncology, vol.30, issue.4, pp.377-88, 2007.
DOI : 10.1097/COC.0b013e31803993f8

M. Hatt, D. Visvikis, O. Pradier, and C. Cheze-le-rest, Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.17, issue.1, pp.1595-606, 2011.
DOI : 10.1007/s00259-011-1834-9

URL : https://hal.archives-ouvertes.fr/inserm-00595534

W. Zhu, X. Sun, L. Xing, M. Li, J. Yue et al., Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification, The British Journal of Radiology, vol.85, issue.1016, pp.383-390, 2012.
DOI : 10.1259/bjr/79854022

. Herskovic-a, W. Russell, M. Liptay, M. Fidler, and M. Sarraf, Esophageal carcinoma advances in treatment results for locally advanced disease: review, Annals of Oncology, vol.23, issue.5, pp.1095-103, 2012.
DOI : 10.1093/annonc/mdr433

S. Vauclin, K. Doyeux, S. Hapdey, and P. Vera, FDG-PET-positive tissue: application to the comparison of three thresholding models, Physics in Medicine and Biology, vol.54, issue.22, pp.6901-6917, 2009.
DOI : 10.1088/0031-9155/54/22/010

URL : https://hal.archives-ouvertes.fr/inserm-00467195

J. Roedl, E. Halpern, R. Colen, D. V. Sahani, A. Fischman et al., Metabolic Tumor Width Parameters as Determined on PET/CT Predict Disease-free Survival and Treatment Response in Squamous Cell Carcinoma of the Esophagus, Molecular Imaging and Biology, vol.35, issue.1, pp.54-60, 2009.
DOI : 10.1007/s11307-008-0169-9

P. Fencl, O. Belohlavek, T. Harustiak, and M. Zemanova, The analysis of factors affecting the threshold on repeated 18F-FDG-PET/CT investigations measured by the PERCIST protocol in patients with esophageal carcinoma, Nuclear Medicine Communications, vol.33, issue.11, pp.1188-94, 2012.
DOI : 10.1097/MNM.0b013e3283573d0d

G. Créhange, M. Bosset, F. Lorchel, F. L. Buffet-miny, J. Dumas et al., Tumor Volume as Outcome Determinant in Patients Treated With Chemoradiation for Locally Advanced Esophageal Cancer, American Journal of Clinical Oncology, vol.29, issue.6, pp.583-590, 2006.
DOI : 10.1097/01.coc.0000242346.25229.48

M. Hatt and D. Visvikis, Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology, European Journal of Nuclear Medicine and Molecular Imaging, vol.51, issue.9, pp.1191-202, 2011.
DOI : 10.1007/s00259-011-1755-7

URL : https://hal.archives-ouvertes.fr/inserm-00574267

E. Levine, M. Farmer, P. Clark, G. Mishra, C. Ho et al., Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer, Annals of Surgery, vol.243, issue.4, pp.472-480, 2006.
DOI : 10.1097/01.sla.0000208430.07050.61

P. Yam, D. Tong, and S. Law, Comparisons of Sixth and Seventh Edition of the American Joint Cancer Committee Staging Systems for Esophageal Cancer, Annals of Surgical Oncology, vol.29, issue.2, 2013.
DOI : 10.1245/s10434-013-3335-5

N. Wu, Z. Chen, L. Pang, Q. Ma, and G. Chen, Prognostische Bedeutung von Lymphknoten-Charakteristika f??r das ??berleben beim Plattenepithelkarzinom des ??sophagus, Wiener klinische Wochenschrift, vol.19, issue.6, pp.26-33, 2013.
DOI : 10.1007/s00508-012-0310-2

D. Situ, W. Wei, P. Lin, H. Long, L. Zhang et al., Do Tumor Grade and Location Affect Survival in Esophageal Squamous Cell Carcinoma? Survival Analysis of 302 Cases of pT3N0M0 Esophageal Squamous Cell Carcinoma, Annals of Surgical Oncology, vol.29, issue.2, pp.580-585, 2013.
DOI : 10.1245/s10434-012-2656-0

M. Bashash, T. Hislop, A. Shah, N. Le, A. Brooks-wilson et al., The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada, BMC Cancer, vol.10, issue.1, p.164, 2011.
DOI : 10.1200/JCO.2003.11.054

M. Eloubeidi, R. Desmond, M. Arguedas, C. Reed, and . Wc, Prognostic factors for the survival of patients with esophageal carcinoma in the U.S., Cancer, vol.72, issue.7, pp.1434-1477, 2002.
DOI : 10.1002/cncr.10868

N. Makris, M. Huisman, and R. Boellaard, Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures, European Journal of Nuclear Medicine and Molecular Imaging, vol.53, issue.Suppl 1, pp.1507-1522, 2013.
DOI : 10.1007/s00259-013-2465-0